These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28973259)

  • 1. New simple radiological criteria proposed for multiple primary lung cancers.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Jpn J Clin Oncol; 2017 Nov; 47(11):1073-1077. PubMed ID: 28973259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of the Standardized Uptake Value on Positron Emission Tomography in Patients with Multiple Clinical-N0 Lung Cancers.
    Hattori A; Suzuki K; Matsunaga T; Takamochi K; Oh S
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):597-603. PubMed ID: 25463357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the radiological definition of part-solid tumour in lung cancer?†.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
    Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
    Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography.
    Shiono S; Yanagawa N; Abiko M; Sato T
    Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):637-43. PubMed ID: 24994703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
    Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
    Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Metastases from NSCLC and MPLC (Multiple Primary Lung Cancers): Management and Outcome in a Single Centre Experience.
    Stella F; Luciano G; Dell'Amore A; Greco D; Ammari C; Giunta D; Bini A
    Heart Lung Circ; 2016 Feb; 25(2):191-5. PubMed ID: 26525847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
    Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.
    Seok Y; Lee E
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):150-155. PubMed ID: 27517168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicoradiological outcomes of 33 cases of surgically resected pulmonary pleomorphic carcinoma: correlation with prognostic indicators.
    Nishida A; Abiru H; Hayashi H; Uetani M; Matsumoto K; Tsuchiya T; Yamasaki N; Nagayasu T; Hayashi T; Kinoshita N; Honda S; Ashizawa K
    Eur Radiol; 2016 Jan; 26(1):25-31. PubMed ID: 25994197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.